Research Topic
Use of CD44v9 as a molecular marker of recurrence and progression of cholangiocarcinoma. For the benefit of prevention and treatment
Researcher
Cholangiocarcinoma Research Institute
Institution
Khon Kaen University
Funding
Thailand Research Fund (TRF)
Timeline
Year 2016-2019